/NOT FOR DISTRIBUTION TO THE
Each Unit will consist of one common share of the Company (each a "Common Share") and one common share purchase warrant (each a "Warrant" and collectively the "Warrants"). Each Warrant will entitle the holder thereof to acquire one Common Share at a price of
The Offering will be conducted by a syndicate led by Echelon as lead underwriter and sole bookrunner. The Company has granted Echelon an option to purchase up to an additional 15% of the Units sold under the Offering, at the Issue Price. The Over-Allotment Option may be exercised in whole or in part to purchase Shares, Warrants or Units as determined by Echelon upon written notice to the Company at any time up to 30 days following the closing date of the Offering (the "Over-Allotment Option").
The Company intends to use the net proceeds of the Offering to expand its retail footprint in
Meta Growth has agreed to grant Echelon a cash commission equal to 7% of the gross proceeds of the Offering (including the Over-Allotment Option), which shall be payable on the closing date of the Offering and/or of the Over-Allotment Option, as applicable.
The Offering will be completed (i) by way of a prospectus supplement to the base shelf prospectus of the Company dated
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of securities in
The Offering is expected to close on or about
About Meta Growth
Meta Growth is a leader in secure, safe and responsible access to legal recreational cannabis in
Cautionary Statements
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward looking statements or information. Forward-looking statements and information in this news release includes, but is not limited to, the Company's intention to complete the Offering and the timing thereof the use of proceeds of the Offering. Although the Company believes that the expectations and assumptions on which the forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company cannot give any assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results and developments may differ materially from those that are currently contemplated by these statements depending on, among other things, receipt of all necessary regulatory approvals, completion of all conditions to closing of the Offering, risks relating to future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; general business, economic, competitive, political, regulatory and social uncertainties; the delay or failure to receive regulatory approvals and the recreational cannabis industry in
"Neither the
SOURCE
© Canada Newswire, source